Justin Q. Gabrielski

Justin Q. Gabrielski

Auto-generated profile, based on publicly available information

Justin Q. Gabrielski

Molecular Development of the Immune System Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
APAnn Y Park
Ann Y Park
MLMichael Leney-Greene
Michael Leney-Greene
MLMatthew Lynberg
Matthew Lynberg
JGJustin Q Gabrielski
Justin Q Gabrielski
XXXijin Xu
Xijin Xu
MLMichael J Lenardo
Michael J Lenardo

8 June 2026 in Nature
Verified
Journal Article
Open access
JCJing Cui
Jing Cui
ZCZuojia Chen
Zuojia Chen
YCYan H. Cheng
Yan H. Cheng
JNJia Nie
Jia Nie
MZMaria H. Zhu
Maria H. Zhu
MLMichael J. Lenardo
Michael J. Lenardo
Inflammatory bowel disease (IBD) causes chronic suffering from gastrointestinal inflammation and dysfunction that can progress to colon cancer 1,2 . The prevalence of the disease is increasing, and there is an urgent need to better understand its pathogenic mechanisms to improve treatment. We show that GPR15—a G-protein-coupled receptor expressed in immune cells and described previously as an entry co-factor for human and simian immunodeficiency viruses 3 —is a marker and homing receptor for a subset of intramucosal GPR15-guided regulatory CD8 + T lymphocytes (CD8 + T IGR cells). Deleterious GPR15 gene variants in humans cause defective homing of CD8 + T IGR cells and are associated with severe early-onset IBD. Moreover, CD8 + T IGR cells are reduced in the intestinal mucosa of individuals with sporadic IBD. In mice, GPR15 deficiency impairs colonic homing of CD8 + T IGR cells, leading to accumulation of inflammatory macrophages and increased susceptibility to colitis. CD8 + T IGR cells potently kill macrophages activated by intestinal damage or disease using Fas ligand and TNF-related weak inducer of apoptosis (TWEAK). The identification of CD8 + T IGR cells yields new insights into organ-specific immune regulation and potential therapeutics for IBD.

12 February 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
APAnn Y. Park
Ann Y. Park
MLMichael Leney-Greene
Michael Leney-Greene
MLMatthew Lynberg
Matthew Lynberg
JGJustin Q. Gabrielski
Justin Q. Gabrielski
XXXijin Xu
Xijin Xu
MLMichael J. Lenardo
Michael J. Lenardo